This case explores the issues entailed in commercialising vaccines in low-income settings. The focus is the dengue vaccine, established at the end of 2015, which was first commercialised in emerging markets.
It considers issues of distribution and affordability, higlighting the requirement for business model innovation in all businesses.
PUBLICATION DATE: January 25, 2016 PRODUCT #: IN1140-HCB-ENG
This is just an excerpt. This case is about INNOVATION & ENTREPRENEURSHIP
Related Case Solutions & Analyses:
Phon-Tech Corporation
Reynolds Metals Co.: Consumer Products Division
Jim Bender and Alert Inc. (A)
The Issue Process for Public Securities
Poland–1989 Supplement
Discounted Cash Flow Exercises
Dhahran Roads A
Jeepers Incorporation
Procter & Gamble PuR Purifier of Water TM (B): A Second Chance
Thought Leader Interview: Richard Thaler
